BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37748508)

  • 21. Adrenocortical carcinoma: current treatment options.
    De Filpo G; Mannelli M; Canu L
    Curr Opin Oncol; 2021 Jan; 33(1):16-22. PubMed ID: 33186181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete Responses to Mitotane in Metastatic Adrenocortical Carcinoma-A New Look at an Old Drug.
    Reidy-Lagunes DL; Lung B; Untch BR; Raj N; Hrabovsky A; Kelly C; Gerst S; Katz S; Kampel L; Chou J; Gopalan A; Saltz LB
    Oncologist; 2017 Sep; 22(9):1102-1106. PubMed ID: 28559412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial.
    Berruti A; Terzolo M; Sperone P; Pia A; Della Casa S; Gross DJ; Carnaghi C; Casali P; Porpiglia F; Mantero F; Reimondo G; Angeli A; Dogliotti L
    Endocr Relat Cancer; 2005 Sep; 12(3):657-66. PubMed ID: 16172198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen.
    Turla A; Laganà M; Grisanti S; Abate A; Ferrari VD; Cremaschi V; Sigala S; Consoli F; Cosentini D; Berruti A
    Endocrine; 2022 Sep; 77(3):438-443. PubMed ID: 35567656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PD-1 Blockade in Advanced Adrenocortical Carcinoma.
    Raj N; Zheng Y; Kelly V; Katz SS; Chou J; Do RKG; Capanu M; Zamarin D; Saltz LB; Ariyan CE; Untch BR; O'Reilly EM; Gopalan A; Berger MF; Olino K; Segal NH; Reidy-Lagunes DL
    J Clin Oncol; 2020 Jan; 38(1):71-80. PubMed ID: 31644329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma.
    Fassnacht M; Hahner S; Polat B; Koschker AC; Kenn W; Flentje M; Allolio B
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4501-4. PubMed ID: 16895957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial.
    Carneiro BA; Konda B; Costa RB; Costa RLB; Sagar V; Gursel DB; Kirschner LS; Chae YK; Abdulkadir SA; Rademaker A; Mahalingam D; Shah MH; Giles FJ
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6193-6200. PubMed ID: 31276163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenocortical Carcinoma: Role of Adjuvant and Neoadjuvant Therapy.
    Kenney L; Hughes M
    Surg Oncol Clin N Am; 2023 Apr; 32(2):279-287. PubMed ID: 36925185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adrenocortical carcinomas: therapeutic advances in 2011].
    Grunenwald S; Caron P
    Ann Endocrinol (Paris); 2011 Oct; 72 Suppl 1():S8-S14. PubMed ID: 22008276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
    Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S
    Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: A Phase 1 Clinical Trial.
    Xiang L; Zhang JW; Lin S; Luo HQ; Wen QL; He LJ; Shang CL; Ren PR; Yang HR; Pang HW; Yang B; He HL; Chen Y; Wu JB
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1027-1034. PubMed ID: 26194678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Histoculture drug response assay guided concurrent chemoradiotherapy for lung metastasis from adrenocortical carcinoma--a case report].
    Yoshimasu T; Oura S; Hirai I; Kokawa Y; Nishida M; Sasaki R; Tanino H; Sakurai T; Okamura Y; Inagaki T; Kodama Y; Shinke T
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):435-7. PubMed ID: 15045957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer.
    Roca E; Berruti A; Sbiera S; Rapa I; Oneda E; Sperone P; Ronchi CL; Ferrari L; Grisanti S; Germano A; Zaggia B; Scagliotti GV; Fassnacht M; Volante M; Terzolo M; Papotti M
    Endocr Relat Cancer; 2017 Jul; 24(7):319-327. PubMed ID: 28432084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenocortical carcinoma.
    van Ditzhuijsen CI; van de Weijer R; Haak HR
    Neth J Med; 2007 Feb; 65(2):55-60. PubMed ID: 17379929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term complete remission of metastatic adrenocortical carcinoma.
    Cárdenas-Salas J; Castelo B; Regojo RM; González-Sanchez JA; Álvarez-Escolá C
    Horm Mol Biol Clin Investig; 2023 Mar; 44(1):67-71. PubMed ID: 36069780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic adrenocortical carcinoma presenting simultaneously with Cushing's and Conn's syndromes: a case report.
    Beom SH; Lee KW; Yang Y; Choi Y; Song KH; Kim YJ; Kim JH; Bang SM; Chung JH; Lee JS
    Jpn J Clin Oncol; 2011 Nov; 41(11):1287-91. PubMed ID: 21980052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient outcome study of concurrent chemoradiation, external beam radiotherapy, and high-dose rate brachytherapy in locally advanced carcinoma of the cervix.
    Forrest JL; Ackerman I; Barbera L; Barnes EA; Davidson M; Kiss A; Thomas G
    Int J Gynecol Cancer; 2010 Aug; 20(6):1074-8. PubMed ID: 20683420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors.
    Henning JEK; Deutschbein T; Altieri B; Steinhauer S; Kircher S; Sbiera S; Wild V; Schlötelburg W; Kroiss M; Perotti P; Rosenwald A; Berruti A; Fassnacht M; Ronchi CL
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4323-4332. PubMed ID: 29092062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma.
    Bedrose S; Miller KC; Altameemi L; Ali MS; Nassar S; Garg N; Daher M; Eaton KD; Yorio JT; Daniel DB; Campbell M; Bible KC; Ryder M; Chintakuntlawar AV; Habra MA
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32737143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
    Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
    Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.